{"id":28001,"date":"2024-04-26T17:53:49","date_gmt":"2024-04-26T21:53:49","guid":{"rendered":"https:\/\/cdtrp.ca\/?page_id=28001"},"modified":"2025-10-30T12:07:17","modified_gmt":"2025-10-30T16:07:17","slug":"treatcovid","status":"publish","type":"page","link":"https:\/\/cdtrp.ca\/en\/treatcovid\/","title":{"rendered":"TREAT-COVID: addressing critical issues and TheRapeutics Emerging in TrAnsplantaTion in COVID-19"},"content":{"rendered":"

<\/span><\/div><\/div>

The pandemic continues to be hard for many transplant recipients and their families and caregivers. COVID-19 vaccines are less effective for transplant recipients. This is due to their suppressed immune systems. As a result, transplant recipients who get COVID-19 are at a higher risk of hospitalization and death. Preventing severe disease in transplant recipients requires different strategies.<\/span><\/p>\n

A New Study<\/strong><\/h4>\n

The CDTRP\u2019s COVID-19 research is centered on addressing patient, family, and caregiver priorities. We have engaged the transplant community to learn how research and policy can support the recovery of quality of life during COVID-19 and in future health concerns<\/p>\n

A new study examines how COVID-19 continues to affect child and adult transplant recipients and their families and caregivers living in Canada. CDTRP will work with 11 transplant centres in Canada. The aim is to create a flexible national plan to inform better policies and improve patient health.<\/span><\/p>\n

The study is called Addressing Critical Issues and Therapeutics Emerging in Transplantation in COVID-19 for Transplant Recipients (TREAT-COVID).<\/strong><\/p>\n

This study will:<\/span><\/p>\n